About Aerami Therapeutics Holdings
Aerami Therapeutics Holdings is a private company based in Durham, North Carolina. It has reported $77,383,423 raised in eight offerings on Form D since August 2016. Its chief executive is Anne Whitaker.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 9, 2023 | Nov 22, 2023 | $1,016,000of $20.0M target | 30 | $33,867 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 31, 2022 | Dec 16, 2022 | $5,380,000of $20.0M target | 39 | $137K | Equity, OptionsRule 506(b) | Form D ↗ |
| Sep 17, 2021 | Sep 23, 2021amended Nov 4, 2021 | $22,250,560fully sold | 238 | $93,490 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 5, 2020 | Jun 17, 2020 | $4,608,000of $15.0M target | 61 | $75,541 | EquityRule 506(b) | Form D ↗ |
| Jan 7, 2019 | Jun 10, 2019amended Jun 11, 2019 | $21,046,000of $59.2M target | 283 | $74,367 | Equity, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Nov 30, 2017 | Dec 18, 2017amended Jan 11, 2018 | $19,033,459of $36.6M target | 135 | $140K | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 7, 2017 | Apr 26, 2017amended Jun 26, 2017 | $3,424,404of $5.0M target | 49 | $69,886 | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 20, 2016 | Aug 4, 2016 | $625,000of $23.0M target | 2 | $312K | Equity, Options, Units consisting of common stock and warrantsRule 506(b) | Form D ↗ |
| Total, eight offerings | $77,383,423 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Aerami Therapeutics Holdings's Form D filed Nov 22, 2023.
Earlier filings also listed Lisa Yanez (executive officer, last listed Dec 2022), Barry Deutsch (chief financial officer, last listed Dec 2022), Timm Crowder (executive officer, last listed Nov 2021), K Bell (executive officer, last listed Nov 2021), Michael Kaseta (chief financial officer, last listed Jun 2020), Kenneth Lee, Jr. (director, last listed Jun 2020), Ben Wolin (director, last listed Jun 2020) and Matt Jennings (director, last listed Jun 2019).
Sources
- SECAerami Therapeutics Holdings, Inc. Form D, filed Sep 23, 2021
- SECAerami Therapeutics Holdings, Inc. Form D, filed Jun 10, 2019
- SECAerami Therapeutics Holdings, Inc. Form D, filed Dec 18, 2017
- SECAerami Therapeutics Holdings, Inc. Form D, filed Apr 26, 2017
- SECAerami Therapeutics Holdings, Inc. filing history